Access to anti-retroviral drugs, male in Bahamas
Bahamas: Access to anti-retroviral drugs, male was 74.0% in 2024. ◆ Volatile
Access to anti-retroviral drugs, male in Bahamas, 2000–2024
Source: UNAIDS estimates. Measured in %.
Analysis
The most recent figure for access to anti-retroviral drugs, male in Bahamas is 74.0%, measured in 2024. That is the highest value across all 25 years on record.
That represents a change of up 7.2% on the previous year and up 51.0% over ten years.
Over the whole period, access to anti-retroviral drugs, male in Bahamas peaked at 74.0% in 2022 and was at its lowest, 0.0%, in 2000.
Bahamas ranks 58th of 141 countries on this measure, in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Access to anti-retroviral drugs, male in Bahamas, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 14.0% | — |
| 2004 | 17.0% | +21.4% |
| 2005 | 21.0% | +23.5% |
| 2006 | 25.0% | +19.0% |
| 2007 | 28.0% | +12.0% |
| 2008 | 26.0% | -7.1% |
| 2009 | 38.0% | +46.2% |
| 2010 | 26.0% | -31.6% |
| 2011 | 26.0% | +0.0% |
| 2012 | 33.0% | +26.9% |
| 2013 | 40.0% | +21.2% |
| 2014 | 49.0% | +22.5% |
| 2015 | 47.0% | -4.1% |
| 2016 | 50.0% | +6.4% |
| 2017 | 65.0% | +30.0% |
| 2018 | 71.0% | +9.2% |
| 2019 | 68.0% | -4.2% |
| 2020 | 70.0% | +2.9% |
| 2021 | 72.0% | +2.9% |
| 2022 | 74.0% | +2.8% |
| 2023 | 69.0% | -6.8% |
| 2024 | 74.0% | +7.2% |
Bahamas compared with similar countries
- Bahamas's 74.0% is below the median for high income countries, which is 82.0%, 90% of the median. (39 countries reporting)
- Bahamas's 74.0% is above the median for Latin America & Caribbean, which is 67.0%, 1.1× the median. (23 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 16.9% | 0.0% | 38.0% | 10 |
| 2010s | 47.5% | 26.0% | 71.0% | 10 |
| 2020s | 71.8% | 69.0% | 74.0% | 5 |
Countries ranked near Bahamas
More gender data for Bahamas
- Child population (UN estimates and projections) 66.27 (2030)
- Child population (UN estimates and projections) (0-14), annual growth -1.06 % change on previous year (2030)
- Population 344 (2030)
- Working-age population (UN estimates and projections) 344 (2030)
- Population (UN estimates and projections), annual growth rate 0.5945 % change on previous year (2030)
- Age population, age 00, female, interpolated 2,126 (2025)
- Age population, age 00, male, interpolated 2,179 (2025)
- Age population, age 01, female, interpolated 2,142 (2025)
- Age population, age 01, male, interpolated 2,194 (2025)
- Age population, age 02, female, interpolated 2,150 (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, male in Bahamas?
- Access to anti-retroviral drugs, male in Bahamas was 74.0% in 2024, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, male recorded in Bahamas?
- The highest recorded value was 74.0% in 2022.
- What is the lowest access to anti-retroviral drugs, male recorded in Bahamas?
- The lowest recorded value was 0.0% in 2000.
- How does Bahamas rank for access to anti-retroviral drugs, male?
- Bahamas ranks 58th out of 141 countries with data for 2024.
- Is access to anti-retroviral drugs, male rising or falling in Bahamas?
- Over the last ten years it is up 51.0%. The long-run trend across the full record is volatile.
- Where does this Bahamas data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, male (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.